Sterile Blood Collection Needle Research: growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report “Sterile Blood Collection Needle- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”. Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Sterile Blood Collection Needle was estimated to be worth US$ 1286 million in 2024 and is forecast to a readjusted size of US$ 2276 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/4784453/sterile-blood-collection-needle
The global sterile blood collection needle market is experiencing significant momentum in 2025, driven by growing demand across clinical, diagnostic, and home-based healthcare segments. According to the Global Sterile Blood Collection Needle Sales Market Report by QYResearch, Competitive Analysis and Regional Opportunities 2025–2031, the market was valued at USD 1.286 billion in 2024 and is projected to reach USD 2.276 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period.
Key Players and Market Landscape
The global market is highly competitive with numerous players operating across developed and emerging regions. Leading manufacturers include:
· Becton, Dickinson and Company
· Terumo Corporation
· Greiner Bio-One
· Sarstedt AG & Co. KG
· Nipro Corporation
· Medtronic
· Weigao Group
· Improve Medical Instruments Co., Ltd.
· Smiths Medical
· B. Braun Melsungen AG
· Yuwell
· Fresenius Kabi
· Sanxin Medical
· Shanghai Kindly Enterprise Development Group
· Needle Gauge/Length: 23 G, 0.75″ (19 mm)
· Tubing: 12″ with preattached holder
· Gammairradiated, sterile; no latex or DEHP
· PentaPoint™ bevel reduces penetration force by 32%
· RightGauge™ ultrathin wall allows smallergauge use without compromising fill time or sample quality
· Singlehanded invein retraction reduces needlestick injuries by up to 88%
· Needle Gauge/Length: 23 G, 0.75″
· Tubing: 7″; includes multisample Luer adapter
· Soft, flexible wings angled to reduce vessel damage
· Onehanded safety activation with hinged shield; latex and DEHPfree
· Packaged in boxes of 50 (500 sets per case)
· Model: NN2125R – 21 G, 1″, thinwall
· Packed 100/box; 10 boxes per case (1,000 needles)
· Manufactured with doublebevel, precisionsharpened for easier penetration
· Up to 10% sharper than competitive BD needles
· Needle Gauge/Length: 25 G, 0.75″
· Tubing: 12″; Luer adapter included
· Hinged safety shield; singlehanded activation; DEHP and latexfree
· Packaged 50 sets per box; ~$104 CAD retail
· Needle Gauge/Length: 30 G, 0.5″ (12 mm); outer diameter 0.3 mm
· Extrathin wall design with 5 μm polyamide filter
· Sterile, for injection use; not for blood collection
· Package quantity: 100 per box; designed to trap particulates during injection
In January 2025, Terumo Corporation unveiled the Terumo Injection Filter Needle as part of its INFINO™ development initiative. This needle incorporates a 5 μm polyamide mesh filter to block particulate contamination during use. With an extra thinwalled 30 G cannula, it delivers significantly improved flow rates—over four times faster than conventional needles—while maintaining injection precision and sterility. Its global launch—from Japan to North America, Europe, and beyond—marks a major leap in ensuring purity and reducing injection-related risks in clinical and intravitreal procedures.
Becton, Dickinson and Company (BD) continues to dominate with its UltraTouch Push-Button Blood Collection Set, designed to minimize user error and injury. The push-button mechanism enables one-handed operation, reduces needlestick incidents, and features a slim, lowforce design that enhances patient comfort. BD’s expansion into developing markets like Southeast Asia reflects a strategic focus on improving clinical safety infrastructure worldwide.
The past year has seen a surge in consumer acceptance of at-home blood sampling solutions. Notably, a Tasso survey in June 2024 reported that approximately one-third of U.S. adults delay tests due to discomfort or inconvenience, yet show strong interest in painless, easy-to-use at-home kits. These devices, including microneedles, dried blood spot (DBS) kits, and lab-on-chip formats, integrate with IoT platforms to enable remote diagnostics and telehealth care—supporting early intervention in chronic conditions like diabetes and cardiovascular disease.
The global blood collection device market, which includes needles, is expected to reach between USD 3.7 and 8.25 billion in 2025, exhibiting growth rates from 5.8 % to 8.7 % CAGR depending on source. This expansion is fueled by elevated diagnostic volumes, point-of-care testing, and healthcare infrastructure growth in emerging markets—particularly across the Asia-Pacific region.
Alongside performance improvements, there is a growing trend toward eco-friendly materials, reduced plastic, and biodegradable packaging. Miniaturized sampling formats—such as finger-prick lancet systems (e.g., BD MiniDraw) and retail-based capillary collections—are gaining traction, offering comparable clinical accuracy in a more accessible and patient-friendly form factor without relying on large-volume draws. These innovations reflect an industry-wide shift toward sustainability and patient-centric care.
The sterile blood collection needle market is segmented by type and application:
· Capillary Blood Collection Needle
· Venous Blood Collection Needle
· Others
· Hospital Blood Collection
· Health Checkup Centers
· Laboratory Sampling
· Home Self-testing
· Others
Of these, home self-testing and health checkup centers are witnessing the fastest growth, especially in India, China, and emerging economies, where public-private healthcare partnerships are driving adoption of safe and disposable diagnostic tools.
While North America remains the largest market in value, growth is accelerating in Asia Pacific—particularly in China, India, and Southeast Asia—due to large population bases, rising health awareness, and government-led initiatives in diagnostic infrastructure.
Europe is also showing stable growth, with companies like Sarstedt AG and Greiner Bio-One focusing on compliance-driven innovations and environmentally friendly materials for single-use needle designs.
Looking ahead to 2031, manufacturers are expected to invest further in automated production lines, safer devices with retractable needles, and materials innovation. The combined forces of aging populations, rising chronic diseases, and global diagnostic demand continue to position the sterile blood collection needle market as a critical sector in global healthcare delivery.
· UMCG Hospital Groningen
· Dallas County Health & Human Services Lab
· LabCorp
· McKesson Medical-Surgical
· VWR International
· Avantor
· Terumo Medical USA
· BD Global Healthcare Network
· Roche Diagnostics
· Banfield Pet Hospitals
· Quest Diagnostics
· Synlab Laboratories
· Singapore General Hospital (SGH)
· Fortis Healthcare
· PathCare Labs
Get free Sample report:
Global Sterile Blood Collection Needle Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
https://www.qyresearch.com/reports/4784455/sterile-blood-collection-needle
Global Sterile Blood Collection Needle Market Research Report 2025
https://www.qyresearch.com/reports/4784454/sterile-blood-collection-needle
Sterile Blood Collection Needle - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
https://www.qyresearch.com/reports/4784453/sterile-blood-collection-needle
Global Sterile Blood Collection Needle Market Insights, Forecast to 2031
https://www.qyresearch.com/reports/4784451/sterile-blood-collection-needle
The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.
The Sterile Blood Collection Needle market is segmented as below:
By Company
Becton, Dickinson and Company
Terumo Corporation
Greiner Bio-One
Sarstedt AG & Co. KG
Nipro Corporation
Medtronic
Weigao Group
Improve Medical Instruments Co., Ltd.
Smiths Medical
B. Braun Melsungen AG
Yuwell
Vitrex Medical A/S
Fresenius Kabi
Jiangsu Kangjian Medical Devices
Shandong Weigao Group Medical Polymer Company Limited
Kawasumi Laboratories Inc.
Shanghai Kindly Enterprise Development Group
Jiangsu Yuyue Medical Equipment
Wuhan HNC Technology Co., Ltd.
CML Biotech Pvt Ltd
FL Medical
Zhejiang Gongdong Medical Technology Co., Ltd.
Sanxin Medical
Shanghai Mekon Medical Devices
Hebei Xinle Sci & Tech Co., Ltd.
Shandong Baolongda Medical Device
Shandong Xinhua Medical Instrument
Guangzhou Improve Medical Instruments
Jiangsu Zhiyu Medical Instrument
Nanchang Kindly Medical Instruments
Segment by Type
Capillary Blood Collection Needle
Venous Blood Collection Needle
Others
Segment by Application
Hospital Blood Collection
Health Checkup Centers
Laboratory Sampling
Home Self-testing
Others
Each chapter of the report provides detailed information for readers to further understand the Sterile Blood Collection Needle market:
Chapter 1: Introduces the report scope of the Sterile Blood Collection Needle report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2020-2031)
Chapter 2: Detailed analysis of Sterile Blood Collection Needle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2020-2025)
Chapter 3: Provides the analysis of various Sterile Blood Collection Needle market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2020-2031)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2020-2031)
Chapter 5: Sales, revenue of Sterile Blood Collection Needle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2020-2031)
Chapter 6: Sales, revenue of Sterile Blood Collection Needle in country level. It provides sigmate data by Type, and by Application for each country/region.(2020-2031)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2020-2025)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Benefits of purchasing QYResearch report:
Competitive Analysis: QYResearch provides in-depth Sterile Blood Collection Needle competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.
Industry Analysis: QYResearch provides Sterile Blood Collection Needle comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.
and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.
Market Size: QYResearch provides Sterile Blood Collection Needle market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.
Other relevant reports of QYResearch:
Global Sterile Blood Collection Needle Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Sterile Blood Collection Needle Market Research Report 2025
Global Sterile Blood Collection Needle Market Insights, Forecast to 2031
About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.